Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Most women with excessive hair growth have a hormonal cause.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

PCOS is a hormonal disorder causing symptoms like irregular periods and acne, and increases the risk of diabetes and heart disease.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

New understanding of hair loss could lead to better treatments.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Hormones and signaling pathways control sebaceous gland function and could help treat acne.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.